Netzmittel RS-16

Hauptinformation

  • Handelsname:
  • Netzmittel RS-16
  • Verwenden für:
  • Pflanzen
  • Art der Medizin:
  • Agrochemisch

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Netzmittel RS-16
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Netz- und Haftmittel

Weitere Informationen

Status

  • Quelle:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Zulassungsnummer:
  • W-7022
  • Letzte Änderung:
  • 06-09-2017

Packungsbeilage

Produkt:

Handelsbezeichnung: Netzmittel RS-16

Produktekategorie

Bewilligungsinhaber

Eidg. Zulassungsnummer

Netz- und Haftmittel

Schneider Formulations

Consulting

W-7022

Stoff(e)

Gehalt

Formulierungscode

Wirkstoff: Polyglykolether

40 % 392.3 g/l

SL Wasserlösliches Konzentrat

Wirkstoff: Ethoxyliertes

Rizinusöl

10 % 98.3 g/l

Anwendungen

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

Obstbau allg.

Erhöhung des Netz- und Haftvermögens Konzentration: 0.2 - 0.4 %

1, 2

W Reben

Erhöhung des Netz- und Haftvermögens Konzentration: 0.2 - 0.4 %

1, 2

Gemüsebau allg. Erhöhung des Netz- und Haftvermögens Konzentration: 0.2 - 0.4 %

1, 2

Feldbau allg.

Erhöhung des Netz- und Haftvermögens

Konzentration: 0.2 - 0.4 %

Aufwandmenge: 0.4 - 0.8

l/ha

1, 2

Zierpflanzen

allg.

Erhöhung des Netz- und Haftvermögens Konzentration: 0.2 - 0.4 %

1, 2

Auflagen und Bemerkungen:

Zusatz zu den durch die Firma zu bestimmenden Mischungspartnern.

Ansetzen der Spritzbrühe: Schutzhandschuhe + Schutzbrille oder Visier tragen.

Gefahrenkennzeichnungen:

Darf nicht in die Hände von Kindern gelangen.

EUH 401 Zur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung

einhalten.

H315 Verursacht Hautreizungen.

H318 Verursacht schwere Augenschäden.

SP 1 Mittel und/oder dessen Behälter nicht in Gewässer gelangen lassen.

Signalwort:

Gefahr

Gefahrensymbole und -bezeichnungen:

Kurzkennzeichnung

GHS05

Symbol

Gefahrenbezeichnung Ätzend

Im Zweifelsfall gelten einzig die Originaldokumente der Zulassung. Die Erwähnung eines Produktes,

Wirkstoffes oder einer Firma stellt keine Empfehlung dar und bedeutet nicht, dass sich das Produkt im

Verkauf befindet.

28-9-2018

Avian influenza overview May – August 2018

Avian influenza overview May – August 2018

Published on: Thu, 27 Sep 2018 00:00:00 +0200 Between 16 May and 15 August 2018, three highly pathogenic avian influenza (HPAI) A(H5N8) outbreaks in poultry establishments and three HPAI A(H5N6) outbreaks in wild birds were reported in Europe. Three low pathogenic avian influenza (LPAI) outbreaks were reported in three Member States. Few HPAI and LPAI bird cases have been detected in this period of the year, in accordance with the seasonal expected pattern of LPAI and HPAI. There is no evidence to date ...

Europe - EFSA - European Food Safety Authority Publications

22-9-2018

Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9

Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9

Published on: Fri, 21 Sep 2018 00:00:00 +0200 The GMO Panel has previously assessed genetically modified (GM) soybean BPS‐CV127‐9. This soybean was found to be as safe and nutritious as its conventional counterpart and commercial soybean varieties with respect to potential effects on human and animal health and the environment in the context of its intended uses. On 16 February 2018, European Commission requested EFSA to analyse new nucleic acid sequencing data and updated bioinformatics data for GM soy...

Europe - EFSA - European Food Safety Authority Publications

20-9-2018

Report of the third Joint Meeting of the ECDC's Food‐ and Waterborne Diseases and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network

Report of the third Joint Meeting of the ECDC's Food‐ and Waterborne Diseases and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network

Published on: Wed, 19 Sep 2018 00:00:00 +0200 The third Joint Meeting of the ECDC's Food‐ and Waterborne Disease and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network was held on 16 and 17 October 2017 in Parma. The meeting was constructed around the principle of ‘One health approach to collaborative response to foodborne disease outbreaks in EU/EEA’ and served as an opportunity for public health authorities and food safety/veterinary authorities to meet and exchange information on the...

Europe - EFSA - European Food Safety Authority Publications

19-9-2018

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

Published on: Tue, 18 Sep 2018 00:00:00 +0200 During the years 2012‐2016, the Dutch National Food Consumption survey was conducted in the Netherlands. For the survey, a random sample was drawn from consumer panels stratified by age and gender and maintained representative to the population with regard to region, address density and educational level. Complete results were obtained for 4,313 persons (response rate 65%); including toddlers, children, adolescents, adults and elderly. Pregnant or lactating ...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Published on: Thu, 16 Aug 2018 00:00:00 +0200 4,15‐Diacetoxyscirpenol (DAS) is a mycotoxin primarily produced by Fusarium fungi and occurring predominantly in cereal grains. As requested by the European Commission, the EFSA Panel on Contaminants in the Food Chain (CONTAM) assessed the risk of DAS to human and animal health related to its presence in food and feed. Very limited information was available on toxicity and on toxicokinetics in experimental and farm animals. Due to the limitations in the avai...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Setting of import tolerances for mandestrobin in strawberries and table and wine grapes

Setting of import tolerances for mandestrobin in strawberries and table and wine grapes

Published on: Thu, 16 Aug 2018 00:00:00 +0200 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Sumitomo Chemical Agro Europe SAS submitted a request to the competent national authority in Austria to set an import tolerance for the active substance mandestrobin in strawberries, table grapes and wine grapes. The data submitted in support of the request were found to be sufficient to derive maximum residue level (MRL) proposals for the crops under consideration. Adequate analytica...

Europe - EFSA - European Food Safety Authority Publications

22-8-2018

Enforcement Report for the Week of August 22, 2018

Enforcement Report for the Week of August 22, 2018

Recently Updated Records for the Week of August 22, 2018 Last Modified Date: Thursday, August 16, 2018

FDA - U.S. Food and Drug Administration

16-8-2018

August 16, 2018: Genesee County Physician and Two Others Charged with Health Care Fraud

August 16, 2018: Genesee County Physician and Two Others Charged with Health Care Fraud

August 16, 2018: Genesee County Physician and Two Others Charged with Health Care Fraud

FDA - U.S. Food and Drug Administration

16-8-2018

Enforcement Report for the Week of August 28, 2013

Enforcement Report for the Week of August 28, 2013

Recently Updated Records for the Week of August 28, 2013 Last Modified Date: Thursday, August 16, 2018

FDA - U.S. Food and Drug Administration

16-8-2018

Boviseal ad us. vet., Suspension in Injektoren

Boviseal ad us. vet., Suspension in Injektoren

● Die Zulassung ist am 16.08.2018 erloschen.

Institut für Veterinärpharmakologie und toxikologie

21-7-2018

Bescheid vom 16.07.2018

Bescheid vom 16.07.2018

Bescheid vom 16.07.2018

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

19-7-2018

Food additive re-evaluation: EFSA workshop in November focuses on foods for infants below 16 weeks of age

Food additive re-evaluation: EFSA workshop in November focuses on foods for infants below 16 weeks of age

Food additive re-evaluation: EFSA workshop in November focuses on foods for infants below 16 weeks of age

Europe - EFSA - European Food Safety Authority Press Releases & News Stories

18-7-2018

Hy-Vee Voluntarily Recalls Spring Pasta Salad Due to Reported Illnesses

Hy-Vee Voluntarily Recalls Spring Pasta Salad Due to Reported Illnesses

WEST DES MOINES, Iowa (July 17, 2018) — Hy-Vee, Inc., based in West Des Moines, Iowa, is voluntarily recalling its Hy-Vee Spring Pasta Salad due to the potential that it may be contaminated with Salmonella. The potential for contamination was brought to Hy-Vee’s attention last night when approximately 20 illnesses in Minnesota, South Dakota, Nebraska and Iowa were potentially linked back to customers consuming the salad. The voluntary recall includes Hy-Vee Spring Pasta Salads in both 1 pound (16 oz.) an...

FDA - U.S. Food and Drug Administration

23-6-2018

Informationsbrief zu Actilyse® Pulver und Lösungsmittel zur Herstellung einer Injektions- bzw. Infusionslösung (Alteplase) bei akutem ischämischen Schlaganfall: Wichtige Anwendungserweiterung bei Jugendlichen ≥ 16 Jahren

Informationsbrief zu Actilyse® Pulver und Lösungsmittel zur Herstellung einer Injektions- bzw. Infusionslösung (Alteplase) bei akutem ischämischen Schlaganfall: Wichtige Anwendungserweiterung bei Jugendlichen ≥ 16 Jahren

Actilyse® wurde zur Behandlung eines akuten ischämischen Schlaganfalls bei jugendlichen Patienten ≥ 16 Jahren zugelassen.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

13-6-2018

Dringende Sicherheitsinformation zu 3-Lumen CVC Kit with Blue FlexTip AGB Catheter: 12 Fr. x 16 cm von ARROW INTERNATIONAL INC

Dringende Sicherheitsinformation zu 3-Lumen CVC Kit with Blue FlexTip AGB Catheter: 12 Fr. x 16 cm von ARROW INTERNATIONAL INC

Weitere Informationen sowie Details zum Produkt entnehmen Sie bitte der anliegenden Kundeninformation des Herstellers.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

1-10-2018

EU/3/16/1762 (Pharma Gateway AB)

EU/3/16/1762 (Pharma Gateway AB)

EU/3/16/1762 (Active substance: Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker) - Transfer of orphan designation - Commission Decision (2018)6399 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/107/16/T/01

Europe -DG Health and Food Safety

1-10-2018

EU/3/05/328 (Celgene Europe B.V.)

EU/3/05/328 (Celgene Europe B.V.)

EU/3/05/328 (Active substance: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone) - Transfer of orphan designation - Commission Decision (2018)6434 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/056/05/T/03

Europe -DG Health and Food Safety

1-10-2018

EU/3/05/279 (Celgene Europe B.V.)

EU/3/05/279 (Celgene Europe B.V.)

EU/3/05/279 (Active substance: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone) - Transfer of orphan designation - Commission Decision (2018)6433 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/001/05/T/03

Europe -DG Health and Food Safety

18-8-2018

EU/3/16/1645 (Salzman Group Ltd)

EU/3/16/1645 (Salzman Group Ltd)

EU/3/16/1645 (Active substance: Cannabidiol) - Transfer of orphan designation - Commission Decision (2018)4806 of Sat, 18 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/248/15/T/01

Europe -DG Health and Food Safety

17-8-2018

EU/3/17/1870 (Pharma Gateway AB)

EU/3/17/1870 (Pharma Gateway AB)

EU/3/17/1870 (Active substance: Thymidine and deoxycytidine) - Transfer of orphan designation - Commission Decision (2018)5403 of Fri, 17 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/317/16/T/01

Europe -DG Health and Food Safety

10-8-2018

Metysolon® 4 mg/8 mg/16 mg

Rote - Liste

7-8-2018

EU/3/16/1756 (Kyowa Kirin Holdings B.V.)

EU/3/16/1756 (Kyowa Kirin Holdings B.V.)

EU/3/16/1756 (Active substance: Mogamulizumab) - Transfer of orphan designation - Commission Decision (2018)5404 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/091/16/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/16/1694 (GlaxoSmithKline Trading Services Limited)

EU/3/16/1694 (GlaxoSmithKline Trading Services Limited)

EU/3/16/1694 (Active substance: Autologous CD4+ and CD8+ T-cells transduced with lentiviral vector containing an affinity-enhanced T-cell receptor targeting the New York esophageal antigen-1) - Transfer of orphan designation - Commission Decision (2018)5405 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/064/16/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/16/1683 (Worphmed Srl)

EU/3/16/1683 (Worphmed Srl)

EU/3/16/1683 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5407 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/007/16/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/16/1682 (Worphmed Srl)

EU/3/16/1682 (Worphmed Srl)

EU/3/16/1682 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5406 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/001/16/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/16/1755 (Worphmed Srl)

EU/3/16/1755 (Worphmed Srl)

EU/3/16/1755 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5408 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/127/16/T/01

Europe -DG Health and Food Safety

2-8-2018

EU/3/16/1660 (Orchard Therapeutics Ltd)

EU/3/16/1660 (Orchard Therapeutics Ltd)

EU/3/16/1660 (Active substance: Autologous CD34+ cells transduced with lentiviral vector encoding the human beta globin gene) - Transfer of orphan designation - Commission Decision (2018)5288 of Thu, 02 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/024/16/T/02

Europe -DG Health and Food Safety

31-7-2018

 CHMP ORGAM minutes for the meeting on 16 July 2018

CHMP ORGAM minutes for the meeting on 16 July 2018

Europe - EMA - European Medicines Agency

31-7-2018

Agenda:  CHMP ORGAM agenda for the meeting on 16 July 2018

Agenda: CHMP ORGAM agenda for the meeting on 16 July 2018

Europe - EMA - European Medicines Agency

27-7-2018

EU/3/16/1635 (Leadiant GmbH)

EU/3/16/1635 (Leadiant GmbH)

EU/3/16/1635 (Active substance: N-acetyl-D-mannosamine monohydrate) - Transfer of orphan designation - Commission Decision (2018)5053 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/228/15/T/01

Europe -DG Health and Food Safety

19-7-2018

EU/3/16/1783 (Reglntel Ltd)

EU/3/16/1783 (Reglntel Ltd)

EU/3/16/1783 (Active substance: N-(5-(6-chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide) - Transfer of orphan designation - Commission Decision (2018)4810 of Thu, 19 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/138/16/T/02

Europe -DG Health and Food Safety

19-7-2018

 Minutes of the CAT meeting 14-16 March 2018

Minutes of the CAT meeting 14-16 March 2018

Europe - EMA - European Medicines Agency

18-7-2018

EU/3/16/1686 (Mereo Biopharma Ireland Ltd)

EU/3/16/1686 (Mereo Biopharma Ireland Ltd)

EU/3/16/1686 (Active substance: Recombinant humanised monoclonal IgG2 lambda antibody against human sclerostin) - Transfer of orphan designation - Commission Decision (2018)4809 of Wed, 18 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/052/16/T/02

Europe -DG Health and Food Safety

18-7-2018

EU/3/16/1718 (Salzman Group Ltd)

EU/3/16/1718 (Salzman Group Ltd)

EU/3/16/1718 (Active substance: Cannabidiol) - Transfer of orphan designation - Commission Decision (2018)4807 of Wed, 18 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/110/16/T/01

Europe -DG Health and Food Safety

16-7-2018

Procox (Bayer Animal Health GmbH)

Procox (Bayer Animal Health GmbH)

Procox (Active substance: emodepside and toltrazuril) - Centralised - Yearly update - Commission Decision (2018)4753 of Mon, 16 Jul 2018

Europe -DG Health and Food Safety

16-7-2018

Reconcile (Nexcyon Pharmaceuticals Ltd)

Reconcile (Nexcyon Pharmaceuticals Ltd)

Reconcile (Active substance: Fluoxetine) - Centralised - Renewal - Commission Decision (2018)4770 of Mon, 16 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/133/R-18

Europe -DG Health and Food Safety

3-7-2018

Jinarc (Otsuka Pharmaceutical Europe Ltd)

Jinarc (Otsuka Pharmaceutical Europe Ltd)

Jinarc (Active substance: tolvaptan) - Centralised - 2-Monthly update - Commission Decision (2018)4243 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2788/II/16

Europe -DG Health and Food Safety

27-6-2018

EU/3/16/1798 (Merck Europe B.V.)

EU/3/16/1798 (Merck Europe B.V.)

EU/3/16/1798 (Active substance: Avelumab) - Transfer of orphan designation - Commission Decision (2018)4090 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/170/16/T/01

Europe -DG Health and Food Safety